Lol :-) I recently told IR how the TLR is still materially insufficient, and they repeated what Missling said, that full data will come in a peer-reviewed journal. They also said they convey investor views on the TLR to Missling.
Suggestion for folks reaching out to IR: don't insult Missling, complain about share price, or raise conspiracy theories. If you want a good interaction with them, act like a biotech investor.
Market Data 
Markets 
AI
